Table 1.
Patient characteristics
| All patients (n = 56) | High isolation (n = 15) | Low isolation (n = 41) | |
|---|---|---|---|
| Age, M (SD), y | 57.8 (12.7) | 58.4 (11.1) | 57.6 (13.4) |
| Marital status, No. (%)* | |||
| Married/living as married | 33 (58.9) | 5 (33.3) | 28 (68.3) |
| Not married | 23 (41.1) | 10 (66.7) | 13 (31.7) |
| Race/ethnicity, No. (%) | |||
| White | 42 (75) | 9 (60) | 33 (80.5) |
| Nonwhite | 14 (25) | 6 (40) | 8 (19.5) |
| Body mass index, M (SD)*, kg/m2 | 26.5 (6.7) | 29.8 (7.3) | 25.2 (6.2) |
| Stage, No. (%) | |||
| Stage I | 26 (46.4) | 8 (53.3) | 18 (43.9) |
| Stage II | 28 (50) | 6 (40.0) | 22 (53.7) |
| Stage III | 2 (3.6) | 1 (6.7) | 1 (2.4) |
| Breast tumor subtype, No. (%)* | |||
| Luminal A | 29 (51.8) | 8 (53.3) | 21 (51.2) |
| Luminal B | 16 (28.6) | 2 (13.3) | 14 (34.1) |
| HER2neu enriched | 3 (5.4) | 3 (20.0) | 0 (0) |
| Triple negative | 8 (14.3) | 2 (13.3) | 6 (14.6) |
| Days from diagnosis to surgery, M (SD) | 38.2 (17.6) | 37.2 (17.7) | 38.6 (17.7) |
| Days from diagnosis to study enrollment, M (SD) | 69.6 (24.6) | 66.6 (25.4) | 70.7 (24.5) |